P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases.
Damiani, D
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases. [electronic resource] - Leukemia Oct 1995 - 1792-5 p. digital
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
0887-6924
ATP Binding Cassette Transporter, Subfamily B, Member 1--physiology
Antibiotics, Antineoplastic--pharmacokinetics
Cyclosporine--administration & dosage
Drug Resistance, Multiple
Humans
Idarubicin--pharmacokinetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Leukocyte Count--drug effects
Male
Middle Aged
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases. [electronic resource] - Leukemia Oct 1995 - 1792-5 p. digital
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
0887-6924
ATP Binding Cassette Transporter, Subfamily B, Member 1--physiology
Antibiotics, Antineoplastic--pharmacokinetics
Cyclosporine--administration & dosage
Drug Resistance, Multiple
Humans
Idarubicin--pharmacokinetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Leukocyte Count--drug effects
Male
Middle Aged